TrialThe Lancet. Respiratory medicine2013

Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.

Lisa Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.